Intuitive Surgical

$404.41$12.46 (+3.18%)
Last updated on --.

Intuitive Surgical price

24 Hours+3.18%+$12.46
30 days+6.84%+$25.07
60 days+6.32%+$23.93
90 days-2.98%-$12.36

About Intuitive Surgical

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Stock ticker
ISRG
Company
Intuitive Surgical, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
13
Launch date
Jun 16, 2000
Listed exchange
NASDAQ

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: ISRG reported Revenue of 2.89B (+18.54%), beating expectations; EPS of 2.80 (+27.85%), beating expectations.

Revenue (USD)Beat2.89B+18.53%2.83B+20.16%66.97M+2.37%
EPS (USD)Beat2.80+27.85%2.48+28.49%0.32+12.90%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.811.952.212.282.35
+23.97%+25.00%+17.55%+18.75%+29.83%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
20.16B19.35B20.63B20.11B20.88B
2.21B2.31B2.69B2.51B2.58B
10.96%11.93%13.03%12.49%12.35%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
715.40M841.00M892.50M911.90M1.06B
+15.29%+19.03%+8.49%+56.79%+48.30%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.8.46%
VANGUARD CAPITAL MANAGEMENT LLC6.52%
STATE STREET CORP4.52%
INVESCO LTD.3.34%
PRICE T ROWE ASSOCIATES INC /MD/3.17%
Others73.96%
Institutions
% Owned87.10%+3.59%
Shares held308.79M+12.39M
Institutions2,355-56
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.8.46%-51.26K
VANGUARD CAPITAL MANAGEMENT LLC6.52%+51.61K
STATE STREET CORP4.52%+216.07K
INVESCO LTD.3.34%+4.39M
PRICE T ROWE ASSOCIATES INC /MD/3.17%-1.26M

Dividends

Stock splits
Launch date: Jun 16, 2000
DateRatio
Oct 5, 20211 → 3
Oct 6, 20171 → 3
Jul 1, 20032 → 1

Intuitive Surgical conversion tables

ISRGISRG
USDUSD
0.5 ISRG202.2 USD
1 ISRG404.41 USD
5 ISRG2,022.07 USD
10 ISRG4,044.14 USD
USDUSD
ISRGISRG
0.5 USD0.0012364 ISRG
1 USD0.0024727 ISRG
5 USD0.012364 ISRG
10 USD0.024727 ISRG

More to explore

FAQ

ISRG is trading at $404.41, +3.18% over the last 24 hours. Track live moves on the price chart at the top of this page.

The ISRG stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ISRG is currently trading at $404.41, +3.18% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ISRG price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ISRG's P/E ratio is currently 45.56 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ISRG; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ISRG's historical range and other companies in the Healthcare sector.

Intuitive Surgical, Inc.'s market cap is currently 141.47B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.